Skip to content

Telesurgery versus Local Surgery in Low-Risk Hepatectomy: A Non-inferiority Randomized Controlled Trial

Telesurgery versus Local Surgery in Low-Risk Hepatectomy: A Non-inferiority Randomized Controlled Trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2600129588
Enrollment
Unknown
Registered
2026-08-06
Start date
2026-09-01
Completion date
Unknown
Last updated
2026-08-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Liver tumor

Interventions

Tele-surgery group:Robot-assisted hepatectomy performed remotely
Local surgery group:Robot-assisted hepatectomy performed locally

Sponsors

The First Medical Center of the General Hospital of the People's Liberation Army
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1. Age between 18 and 75 years old, with no gender restrictions; 2. ECOG performance status score of 0-1; 3. American Society of Anesthesiologists (ASA) classification of grade I-II; 4. To undergo one of the following three surgical types: (1) Left lateral lobe liver resection; (2) Anatomic liver segmentectomy of <= 2 liver segments; (3) Non-anatomic wedge liver resection; 5. Physiological conditions suitable for robot-assisted laparoscopic surgery; 6. And willing to cooperate and complete the research follow-up and related examinations.

Exclusion criteria

Exclusion criteria: 1. The patient or their legal representative refuses to sign the informed consent form and refuses to participate in this study; 2. There are serious complications in vital organs such as heart, lungs, kidneys, etc., and there are contraindications for anesthesia or surgery; 3. Preoperative imaging examinations indicate that the tumor has invaded adjacent organs or there is distant metastasis; 4. There is a previous history of surgery on the same side of the liver; 5. There is an uncorrectable coagulation disorder (INR > 1.5 or platelet count < 50 x 10^9/L); 6. Pregnant or lactating women; 7. Severe mental illness or cognitive dysfunction, unable to cooperate with the research process; 8. Within 3 months before enrollment, is participating in other clinical trials that may affect the outcome indicators of this study.

Design outcomes

Primary

MeasureTime frame
Surgical success rate (composite endpoint);

Secondary

MeasureTime frame
Incidence of perioperative complications;Length of Stay;Postoperative recovery indicators;Postoperative quality of life;Remote surgery technical parameters;Workload of the medical team;The time for the first intake of liquid food after the surgery;The first time to get out of bed for activities;Time for removal of abdominal drainage tube;The rate of secondary surgeries within 30 days after the operation;The re-admission rate within 30 days after surgery;All-cause mortality rate 90 days after surgery;Removal rate of R0;Distance of surgical margin;

Countries

China

Contacts

Public ContactRong Liu

The First Medical Center of the General Hospital of the People's Liberation Army

liurong301@126.com+86 10 6693 7591

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Aug 25, 2026